Abdominal obesity and levels of inflammatory markers and adipokines in young people with hypertension

   Objective: to investigate pro- and anti-inflammatory markers and blood adipokines in young people with arterial hypertension (AH) on the background of abdominal obesity (AO).

   Materials and methods. 510 people were included in the study, of which 257 people with hypertension, of which 164 were with AO. In the control group (without AH) there were 253 people of comparable gender and age, with AO – 101 people. The content of adipsin, lipocalin-2, resistin, TNF-α, IL-6, IL-8, IL-10, IL-17a, IL-17e, IL-17f was determined in all blood by multiplex analysis. Statistical processing was carried out in the SPSS 13.0 program.

   Results. When comparing the studied parameters in the studied groups, statistically significant differences were obtained for lipocalin-2, resistin, adipsin, IL-6 and IL-17a, all these indicators were higher in the group with hypertension. There was no difference between the control and the group with hypertension in other biomarkers. There was no effect of AO on the level of the studied markers in the control group. For the main group, the difference between the subgroups with and without AO was obtained for lipocalin. Also, the systolic pressure level was significantly higher in the group with AO. Correlation analysis revealed a weak association of systolic and diastolic blood pressure with TNF-α, IL-6, adipsin, lipocalin-2, resistin and waist circumference. the association of body mass index with lipocalin-2, IL-6 and TNF-α (p < 0.01), a strong association of adipsin, lipocalin-2, resistin with TNF-α and IL-17a (p < 0.01).

   Conclusion. Of the markers we studied, elevated levels of adipsin, lipocalin-2, resistin, IL-6 and IL-17a can serve as potential biomarkers indicating a high probability of developing early hypertension in people under 45 years of age. Systolic and diastolic blood pressure levels also increase with an increase in waist circumference.

1. Chazova I.E., Chikhladze N.M., Blinova N.V., Belaya Zh.E., Danilov N.M., Elfimova E.M., Litvin A.Yu., Rozhinskaya L.Ya., Sviridenko N.Yu., Shvetsov M.Yu., Azizov V.A., Grigorenko E.A., Mitkovskaya N.P., Mustafaev I.I., Polupanov A.G., Sarybaev A.Sh., Khamidullaeva G.A. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eur. Cardiol. J., 2023; (1): 6–65. (In Russ.). doi: 10.38109/2225-1685-2023-1-6-65

2. Benjamin E.J., Blaha M.J., Chiuve S.E., Cushman M., Das S.R., Deo R., de Ferranti S.D., Floyd J., Fornage M., Gillespie C., Isasi C.R., Jimйnez M.C., Jordan L.C., Judd S.E., Lackland D., Lichtman J.H., Lisabeth L., Liu S., Longenecker C.T., Mackey R.H., Matsushita K., Mozaffarian D., Mussolino M.E., Nasir K., Neumar R.W., Palaniappan L., Pandey D.K., Thiagarajan R.R., Reeves M.J., Ritchey M., Rodriguez C.J., Roth G.A., Rosamond W.D., Sasson C., Towfighi A., Tsao C.W., Turner M.B., Virani S.S., Voeks J.H., Willey J.Z., Wilkins J.T., Wu J.H., Alger H.M., Wong S.S., Muntner P. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation, 2017; 135 (10): 146–603. doi: 10.1161/CIR.0000000000000485

3. Balanova Yu.A., Shalnova S.A., Imaeva A.E., Kapustina A.V., Muromtseva G.A., Evstifeeva S.E., Tarasov V.I., Redko A.N., Viktorova I.A., Prishchepa N.N., Yakushin S.S., Boytsov S.A., Drapkina O.M., Konstantinov V.V., Pokrovskaya M.S., Efimova I.A., Sivakova O.V., Alekseenko S.N., Gubarev S.V., Livzan M.A., Zhuravleva I.A., Rozhkova M.Yu., Vezikova N.N., Skopets I.S., Filippov E.V., Dobrynina N.V., Nikulina N.N., Pereverzeva K.G., Moseychuk K.A. Prevalence of arterial hypertension, treatment and its effectiveness in Russian Federation (The data of observational study ESSE-RF 2). The Rational Pharmakotherapy in Cardiology, 2019; 14 (5): 450–466. (In Russ.). doi: 10.20996/1819-6446-2019-15-4-450-466

4. Zhernakova Yu.V., Zheleznova E.A., Chazova I.E., Oshchepkova E.V., Dolgusheva Yu.A., Yarovaya E.B., Blinova N.V., Orlovsky A.A., Konosova I.D., Shalnova S.A., Rotar’ O.P., Konradi A.O., Shlyakhto E.V., Boytsov S.A., Balanova Yu.A., Evstifeeva S.E., Kapustina A.V., Konstantinov V.V., Muromtseva G.A., Oganov R.G., Mamedov M.N. The prevalence of abdominal obesity in the constituent entities of the Russian Federation and its relationship with socio-economic status, results of an epidemiological study ESSE-RF. Therapeutic archive, 2018; 90 (10): 14–22. (In Russ.). URL: https://www.researchgate.net/publication/342545966_The_prevalence_of_abdominal_obesity_and_the_association_with_socioeconomic_status_in_Regions_of_the_Russian_Federation_the_results_of_the_epidemiological_study_-_ESSE-RF/fulltext/5efaa302a6fdcc4ca43d8967/The-prevalence-of-abdominal-obesity-and-the-association-with-socioeconomic-status-in-Regions-of-the-Russian-Federation-the-results-of-the-epidemiological-study-ESSE-RF.pdf

5. Kobalava Z.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I., Barbarash O.L., Boitsov S.A., Vavilova T.V., Villevalde S.V., Galyavich A.S., Glezer M.G., Grineva E.N., Grinstein Yu.I., Drapkina O.M., Zhernakova Yu.V., Zvartau N.E., Kislyak O.A., Koziolova N.A., Kosmacheva E.D., Kotovskaya Yu.V., Libis R.A., Lopatin Yu.M., Nebiridze D.V., Nedoshivin A.O., Ostroumova O.D., Oschepkova E.V., Ratova L.G., Skibitsky V.V., Tkacheva O.N., Chazova I.E., Chesnikova A.I., Chumakova G.A., Shalnova S.A., Shestakova M.V., Yakushin S.S., Yanishevsky S.N. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology, 2020; 25 (3): 3786. (In Russ). doi: 10.15829/1560-4071-2020-3-3786

6. Aguayo A.K.G., Lista F.J.M.; Herrera M.Á.R., Hernández B.S., Ortega MG., Rizo V.D., Martín E.V., Trujillo X.; Nava J.G., Muñoz E.C., Alfonso M.F. Lipocalin-2 correlates with arterial stiffness in obese patients. Journal of Hypertension, 2021; 39, p e109. doi: 10.1097/01.hjh.0000745520.21980.d2

7. Dare A., Chen S.Y. Adipsin in the pathogenesis of cardiovascular diseases. Vascul Pharmacol., 2024; 154: 107270. doi: 10.1016/j.vph.2023.107270

8. Ohtsuki T., Satoh K., Shimizu T., Ikeda S., Kikuchi N., Satoh T., Kurosawa R., Nogi M., Sunamura S., Yaoita N., Omura J., Aoki T., Tatebe S., Sugimura K., Takahashi J., Miyata S., Shimokawa H. Identification of adipsin as a novel prognostic biomarker in patients with coronary artery disease. J. Am. Heart. Assoc., 2019; 8 (23): e013716. doi: 10.1161/JAHA.119.013716

9. Farkhondeh T., Llorens S., Pourbagher-Shahri A.M., Ashrafizadeh M., Talebi M., Shakibaei M., Samarghandian S. An overview of the role of adipokines in cardiometabolic diseases. Molecules, 2020; 25 (21): 5218. doi: 10.3390/molecules25215218

10. Khachirova A.I. Interleukin-6 content in men with arterial hypertension with moderate and high cardiovascular risk. Atheroscleroz, 2023; 19 (3): 257–258. (In Russ.). doi: 10.52727/2078-256X-2023-19-3-257-258

11. Smirnova E.N., Shulgina S.G. Dynamics of the level of leptin, soluble leptin receptors, free leptin index and resistin during weight loss in patients with arterial hypertension associated with obesity. Arterial Hypertension. 2016; 22 (4): 382–388. (In Russ.). doi: 10.18705/1607-419X-2016-22-4-382-388

12. Niaz S., Latif J., Hussain S. Serum resistin: A possible link between inflammation, hypertension and coronary artery disease. Pak. J. Med. Sci., 2019; 35 (3): 641–646. doi: 10.12669/pjms.35.3.274

13. Adamenko G.P., Golovko E.S., Skreblo E.I., Tikhon T.V. Markers of intravascular inflammation and cytokine profile in arterial hypertension. Health and Environmental Problems, 2014; (2): 40–44. (In Russ.). doi: 10.51523/2708-6011.2014-11-2-8

14. Suranova G.Zh., Maynazarova E.S., Tuhvatshin R.R. Analysis of cytokine levels in patients with atherosclerosis of peripheral vessels under conditions of technological pollution. RMJ, 2018; 11 (1): 27–30. (In Russ.)

15. Plante T.B., Juraschek S.P., Howard G., Howard V.J., Tracy R.P., Olson N.C., Judd S.E., Kamin Mukaz D., Zakai N.A., Long D.L., Cushman M. Cytokines, C-reactive protein, and risk of incident hypertension in the REGARDS study. Hypertension, 2024; 81 (6): 1244–1253. doi: 10.1161/HYPERTENSIONAHA.123.22714

16. Ji Q., Cheng G., Ma N., Huang Y., Lin Y., Zhou Q., Que B., Dong J., Zhou Y., Nie S. Circulating Th1, Th2, and Th17 levels in hypertensive patients. Dis. Markers, 2017; 2017: 7146290. doi: 10.1155/2017/7146290

17. Agarkov N.M., Markelova E.A., Markelov M.Yu., Konyaev D.A., Lutai Yu.A. Cytokine profile of elderly patients with metabolic syndrome and arterial hypertension. Clin. Gerontol., 2020; 26 (5-6): 5–10. (In Russ.). doi: 10.26347/1607-2499202005-06005-010